Roger Adsett's Net Worth
$12.5 Million
Who is Roger Adsett?
Roger Adsett has an estimated net worth of $12.5 Million. This is based on reported shares across multiple companies, which include INSMED Inc, and Landos Biopharma, Inc..
SEC CIK
Roger Adsett's CIK is 0001685904
Past Insider Trading and Trends
2022 was Roger Adsett's most active year for acquiring shares with 6 total transactions. Roger Adsett's most active month to acquire stocks was the month of December. 2024 was Roger Adsett's most active year for disposing of shares, totalling 9 transactions. Roger Adsett's most active month to dispose stocks was the month of December. 2018 saw Roger Adsett paying a total of $47,907.00 for 99,564 shares, this is the most they've acquired in one year. In 2022 Roger Adsett cashed out on 21,315 shares for a total of $450,076.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INSMED Inc (INSM) Snapshot price: $71.04
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.83% | -5.95K |
$25.09 | -$149,160.05 | 149.28K |
Scheduled
|
May 17
| ||
Form 4
| +4.48% | 6.66K |
$25.50 | -$200,353.50 | 155.22K |
May 13 - May 14
| |||
Form 4
| -3.41% | -5.25K |
$28.63 | -$150,336.13 | 148.56K |
Scheduled
|
Jan 12
| ||
Form 4
| -4.57% | -7.37K |
$29.08 | -$214,422.65 | 153.81K |
Scheduled
|
Jan 9 - Jan 10
| ||
Form 4
| +6.50% | 9.83K |
$29.21 | -$88,864.42 | 161.18K |
Jan 4 - Jan 5
| |||
Form 4
| -5.60% | -8.98K |
$19.32 | -$173,512.92 | 151.35K |
Jun 13
| |||
Form 4
| -4.08% | -6.82K |
$18.66 | -$127,190.64 | 160.33K |
May 15 - May 17
| |||
Form 4
| +23.37% | 31.66K |
—
|
—
| 167.15K |
May 11
| |||
Form 4
| -2.30% | -3.19K |
$17.99 | -$57,460.06 | 135.49K |
Jan 10
| |||
Form 4
| +3.40% | 4.55K |
$19.75 | -$60,119.00 | 138.68K |
Jan 5
| |||
Form 4
| -8.12% | -11.86K |
$18.80 | -$222,874.00 | 134.13K |
Nov 22
| |||
Form 4
| -2.29% | -3.42K |
$19.57 | -$66,846.78 | 145.98K |
May 16 - May 17
| |||
Form 4
| +22.52% | 27.46K |
—
|
—
| 149.4K |
May 11
| |||
Form 4
| -0.99% | -1.22K |
$24.58 | -$29,913.86 | 121.94K |
Jan 12
| |||
Form 4
| +16.82% | 17.73K |
—
|
—
| 123.16K |
Jan 6
| |||
Form 4
| -4.38% | -4.83K |
$27.02 | -$130,441.48 | 105.42K |
Jan 5 - Jan 6
| |||
Form 4
| -2.20% | -2.48K |
$26.23 | -$64,971.71 | 110.25K |
May 15
| |||
Form 4
| +14.38% | 14.17K |
—
|
—
| 112.72K |
May 12
| |||
Form 4
| +12.59% | 11.02K |
—
|
—
| 98.55K |
Jan 7
| |||
Form 4
| -5.60% | -5.19K |
$30.77 | -$159,634.81 | 87.53K |
May 15 - Jan 4
| |||
Form 4
| +36.72% | 24.9K |
$23.75 | -$33,582.50 | 92.72K |
Jan 3
| |||
Form 4
| +57.88% | 24.86K |
—
|
—
| 67.82K |
Nov 18
| |||
Form 4
| +109.94% | 21.56K |
—
|
—
| 41.17K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +19.24% | 3K |
$15.97 | $47,907.00 | 18.59K |
Nov 1
| |||
Form 4
|
∞
| 15.59K |
—
|
—
| 15.59K |
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Landos Biopharma, Inc. (LABP) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||